Medical Properties Trust Stock Cash Flow From Operations
M3P Stock | EUR 3.44 0.11 3.10% |
Fundamental analysis of Medical Properties allows traders to better anticipate movements in Medical Properties' stock price by examining its financial health and performance throughout various phases of its business cycle.
Medical |
Medical Properties Trust Company Cash Flow From Operations Analysis
Medical Properties' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Medical Properties Cash Flow From Operations | 811.66 M |
Most of Medical Properties' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Properties Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Competition |
In accordance with the recently published financial statements, Medical Properties Trust has 811.66 M in Cash Flow From Operations. This is 83.77% higher than that of the Real Estate sector and 65.2% higher than that of the REIT - Healthcare Facilities industry. The cash flow from operations for all Germany stocks is 16.43% higher than that of the company.
Medical Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Properties' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medical Properties could also be used in its relative valuation, which is a method of valuing Medical Properties by comparing valuation metrics of similar companies.Medical Properties is currently under evaluation in cash flow from operations category among its peers.
Medical Fundamentals
Return On Equity | 0.11 | |||
Return On Asset | 0.0325 | |||
Profit Margin | 0.57 % | |||
Operating Margin | 0.66 % | |||
Current Valuation | 15.57 B | |||
Shares Outstanding | 597.48 M | |||
Shares Owned By Insiders | 1.28 % | |||
Shares Owned By Institutions | 84.90 % | |||
Price To Earning | 5.91 X | |||
Price To Book | 0.80 X | |||
Price To Sales | 4.22 X | |||
Revenue | 1.54 B | |||
Gross Profit | 1.54 B | |||
EBITDA | 1.34 B | |||
Net Income | 902.6 M | |||
Cash And Equivalents | 995.55 M | |||
Cash Per Share | 2.52 X | |||
Total Debt | 10.27 B | |||
Debt To Equity | 83.90 % | |||
Current Ratio | 12.27 X | |||
Book Value Per Share | 14.38 X | |||
Cash Flow From Operations | 811.66 M | |||
Earnings Per Share | 1.41 X | |||
Target Price | 23.42 | |||
Number Of Employees | 21 | |||
Beta | 0.97 | |||
Market Capitalization | 5.99 B | |||
Total Asset | 19.66 B | |||
Annual Yield | 0.11 % | |||
Five Year Return | 6.05 % | |||
Net Asset | 19.66 B | |||
Last Dividend Paid | 1.16 |
About Medical Properties Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Properties Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Properties using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Properties Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
RYCEY | Rolls Royce Holdings | |
VSAT | ViaSat Inc | |
CIG | Companhia Energetica de | |
ATEX | Anterix | |
BBAI | BigBearai Holdings |
Additional Information and Resources on Investing in Medical Stock
When determining whether Medical Properties Trust is a strong investment it is important to analyze Medical Properties' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medical Properties' future performance. For an informed investment choice regarding Medical Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.